SEATTLE (AP) _ Omeros Corporation (OMER) on Thursday reported a loss of $19.6 million in its fourth quarter.
The Seattle-based company said it had a loss of 45 cents per share. Losses, adjusted to extinguish debt and for pretax expenses, were 20 cents per share.
The drug developer posted revenue of $12.9 million in the period.
For the year, the company reported that its loss narrowed to $66.7 million, or $1.65 per share. Revenue was reported as $41.6 million.
Omeros shares have increased 17 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $11.60, a decline of 19 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMER at https://www.zacks.com/ap/OMER
Keywords: Omeros, Earnings Report